Literature DB >> 12431667

Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation.

N M van Besouw1, A H M M Balk, M van Vliet, P H van der Meide, A P W M Maat, T van Gelder, C C Baan, W Weimar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12431667     DOI： 10.1016/s0041-1345(02)03498-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Murine cytomegalovirus promotes renal allograft inflammation via Th1/17 cells and IL-17A.

Authors:  Ravi Dhital; Shashi Anand; Brianna Graber; Qiang Zeng; Victoria M Velazquez; Srinivasa R Boddeda; James R Fitch; Ranjana W Minz; Mukut Minz; Ashish Sharma; Rachel Cianciolo; Masako Shimamura
Journal:  Am J Transplant       Date:  2022-06-15       Impact factor: 9.369

2.  Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots.

Authors:  Joshua J Augustine; Emilio D Poggio; Peter S Heeger; Donald E Hricik
Journal:  Transplantation       Date:  2008-08-27       Impact factor: 4.939
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.